Health professionals: How do they assess new medicines?

Pharmacy World and Science

Volumn 27, Issue 3, 2005, Pages 236-242

  Cheng, Rebecca ^a   Cook, Kirsty ^a   Dowman, Sarah ^a   Lawn, Rebecca ^a   Leary, Jemma ^a   Quinn, Taryn ^a   Schroder, Kim ^a   Smith, Nicola ^a   Tordoff, June ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Decision making; Drug; New Zealand; Nurse; Pharmacist; Pharmacoeconomics; Physician; Safety

Indexed keywords

CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG INFORMATION; DRUG SAFETY; HEALTH PRACTITIONER; HUMAN; MEDICAL RESEARCH; NEW ZEALAND; NURSE; PHARMACIST; PHYSICIAN; PUBLICATION; QUESTIONNAIRE; REVIEW; SURGEON; TREATMENT CONTRAINDICATION;

COST-BENEFIT ANALYSIS; CROSS-SECTIONAL STUDIES; DATA COLLECTION; DRUG INDUSTRY; DRUG THERAPY; INTERNET; NEW ZEALAND; NURSES; PERSONNEL, HOSPITAL; PHARMACEUTICAL PREPARATIONS; PHARMACISTS; PHYSICIANS; PUBLISHING; QUESTIONNAIRES; REFERRAL AND CONSULTATION; RISK REDUCTION BEHAVIOR;

EID: 23844505614     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-004-3706-x     Document Type: Review

References (33)

1. R Segal S. Pathak 1988 Formulary decision making: identifying factors that influence P&T Committee drug evaluations Hosp Formul 23 174 8
2. LM Weekes C. Brooks 1996 Drug and therapeutics committees in Australia: expected and actual performance Br J Clin Pharmacol 42 5 551 7
3. Medicines Pharmacy and Industry Group and Nursing and Midwifery Policy Branch. (2003). Supplementary prescribing by nurses and pharmacists within the NHS in England. Department of Health: London, 1-67
4. S. Gentry 2001 Nurse Prescribing Regulations take effect. Media Release Ministry of Health Wellington
5. Anon 1998 Prescribing new drugs in general practice MeRec Bull 9 6 21 4
6. P. McGettigan 2001 Prescribers prefer people. The sources of information used by doctors for prescribing suggest that the medium is more important than the message Br J Clin Pharmacol 51 184 9
7. MI Jones SM Greensfield CP. Bradley 2000 Prescribing new drugs: qualitative study of influences on consultants and general practitioners BMJ 323 378 2
8. H Prosser A Solomon T. Walley 2003 Influences on GP's decision to prescribe new drugs - the importance of who says what Fam Pract 20 1 61 8
9. MY Peay ER. Peay 1984 Differences among practitioners in patterns of preference for information sources in the adoption of new drugs Soc Sci Med 18 1019 25
10. J Hall J Cantrill P. Noyce 2003 The information sources used by community nurse prescribers Br J Nurs 12 13 810 8
11. J Glanville M Haines I. Auston 1998 Finding information on clinical effectiveness BMJ 317 200 3
12. W Rosenberg A. Donald 1995 Evidence based medicine: an approach to clinical problem-solving BMJ 310 1122 6
13. A Laupacis D Sackett R. Roberts 1996 An assessment of clinically useful measures of the consequences of treatment N Engl J Med 318 26 1728 33
14. JP McCormack M. Levine 1993 Meaningful interpretation of risk reduction from clinical drug trials Ann Pharmacother 27 10 1272 7
15. Fahey T, Newton J. (1995). Conveying the benefits and risks of treatment. Br J Gen Pract (45): 339-41
16. RJ Cook DL. Sackett 1995 The number needed to treat: a clinically useful measure of treatment effect BMJ 310 452 4
17. M Cranney T. Walley 1996 Same information, different decisions: The influence of evidence on the management of hypertension in the elderly Br J Gen Pract 46 661 3
18. DC Naylor E Chen B. Strauss 1992 Measured enthusiasm. Does the method of reporting trial results alter perceptions of therapeutics effectiveness? Ann Int Med 117 11 916 21
19. HC Bucher M Weinbacher K. Gyr 1994 Influence of method of reporting study results on decision of physicians to prescribe drugs to lower cholesterol concentration BMJ 309 761 5
20. MDB Bobbio G. Giustetto 1994 Completeness of reporting trial results: effect on physicians willingness to prescribe Lancet 343 1209 11
21. L Forrow WC Taylor RM. Arnold 1992 Absolutely relative: how research results are summarised can affect treatment decisions Am J Med 92 121 4
22. D Walzak S Swindells A. Bhardwaj 1994 Primary Care physicians and the cost of drugs: a study of prescribing practices based on recognition of information sources J Clin Pharmacol 34 1159 63
23. S Reichert T Simon EA. Halm 2000 Physicians' attitudes about prescribing and knowledge of the costs of common medications Arch Intern Med 160 2799 803
24. M Drummond J Cooke T. Walley 1997 Economic evaluation under managed competition: evidence from the UK Soc Sci Med 45 4 583 95
25. C Hoffmann 2002 Do health-care decision makers find economic evaluations useful? The findings of focus group research in UK health authorities Value Health 5 2 71 8
26. FT Odedina 2002 Use of pharmacoeconomic data in making hospital formulary decisions Am J Health Syst Pharm 59 15 1441 4
27. Tordoff J et al. Processes for the assessment of new medicines in New Zealand hospitals. Annual Scientific Meeting, 2003. Sydney: Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists
28. G. Kobelt 2002 Health economics: An introduction to economic evaluation 2 Office of Health Economics London
29. MF Drummond 1996 Methods for the economic evaluation of health programmes 2 Oxford University Press Oxford
30. Pharmaceutical Management Agency. Prescription for pharmacoeconomic analysis. 1999. Available at http://www. pharmac.govt.nz/pdf (accessed on 5.12.03)
31. Australian Department of Health Housing and Community Services. Guidelines for the pharmaceutical industry on preparation of submissions to the Pharmaceutical Benefits Advisory Committee. Australian Government Publishing Service: Canberra, Australia, 1922
32. R Elliott K Payne J. Silcock 1996 Health economics - do or be done by Pharm J 257 832
33. NA. Barber 1986 Pharmacists' guide to statistics Br J Pharm Pract 8 354 7